International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 4 , Pages 1114-1120 , 15 July 2009

The Results of Surgery, With or Without Radiotherapy, for Primary Spinal Myxopapillary Ependymoma: A Retrospective Study From the Rare Cancer Network

  • Alessia Pica, M.D.

      Affiliations

    • Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
    • ,
  • Robert Miller, M.D.

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA
    • ,
  • Salvador VillÀ, M.D.

      Affiliations

    • Catalan Institute of Oncology, Badalona, Barcelona, Spain
    • ,
  • Sidney P. Kadish, M.D.

      Affiliations

    • University of Massachusetts Medical School, Worcester, MA
    • ,
  • Yavuz Anacak, M.D.

      Affiliations

    • Department of Radiation Oncology, Ege University Medical School, Izmir, Turkey
    • ,
  • Huda Abusaris, M.D.

      Affiliations

    • Dr Bernard Verbeeten Instituut, Tilburg, The Netherlands
    • ,
  • Gokhan Ozyigit, M.D.

      Affiliations

    • Hacettepe University, Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey
    • ,
  • Brigitta G. Baumert, M.D., Ph.D.

      Affiliations

    • Radiation therapy, MAASTRO, GROW, Maastricht, The Netherlands
    • ,
  • Renata Zaucha, M.D.

      Affiliations

    • Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland
    • ,
  • Guy Haller, M.D.

      Affiliations

    • Department of Clinical Epidemiology and Statistics, Geneva University Hospital, University of Geneva, Switzerland
    • ,
  • Damien C. Weber, M.D.

      Affiliations

    • Department of Radiation Oncology, Geneva University Hospital, University of Geneva, Switzerland
    • Corresponding Author InformationReprint requests to: Dr.med. Damien C. Weber, Radiation Oncology Department, Département de l'Imagerie et Science de l'Information Médical (DISIM), Geneva University Hospital, CH-1211 Geneva 14, Switzerland. Tel: (+41) 22 38 27 090; Fax: (+41) 22 38 27 117

Received 13 June 2008 ,Revised 4 September 2008 ,Accepted 6 September 2008.

References 

  1. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer. 2000;88:2887
  2. Kahan H, Sklar EM, Post MJ, et al. MR characteristics of histopathologic subtypes of spinal ependymoma. AJNR Am J Neuroradiol. 1996;17:143–150
  3. Gilhuis HJ, van der Laak J, Wesseling P, et al. Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: A paradox?. J Neurooncol. 2004;66:111–116
  4. Hirose Y, Aldape K, Bollen A, et al. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. 2001;158;1137–1143.
  5. Yu YL, Crockard HA, Smith JJ, et al. Extraspinal ependymoma at the cervicothoracic junction. Surg Neurol. 1982;17:160–162
  6. Schroder R, Firsching R, Kochanek S. Hemangiopericytoma of meninges. II. General and clinical data. Zentralbl Neurochir. 1986;47:191–199
  7. Warnick RE, Raisanen J, Adornato BT, et al. Intracranial myxopapillary ependymoma: case report. J Neurooncol. 1993;15:251–256
  8. Akyurek S, Chang EL, Yu TK, et al. Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center. J Neurooncol. 2006;80:177–183
  9. Sonneland PR, Scheithauer BW, Onofrio BM. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer. 1985;56:883–893
  10. Woesler B, Moskopp D, Kuchelmeister K, et al. Intracranial metastasis of a spinal myxopapillary ependymoma. A case report. Neurosurg Rev. 1998;21:62–65
  11. Jatana KR, Jacob A, Slone HW, et al. Spinal myxopapillary ependymoma metastatic to bilateral internal auditory canals. Ann Otol Rhinol Laryngol. 2008;117:98–102
  12. Wight DG, Holley KJ, Finbow JA. Metastasizing ependymoma of the cauda equina. J Clin Pathol. 1973;26:929–935
  13. Plans G, Brell M, Cabiol J, et al. Intracranial retrograde dissemination in filum terminale myxopapillary ependymomas. Acta Neurochir (Wien). 2006;148:343–346discussion 346
  14. Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia. 1969;7:179–192
  15. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1–39
  16. Cox D. Regression models and life tables. J R Stat Soc. 1972;34:187–220
  17. Helwig EB, Stern JB. Subcutaneous sacrococcygeal myxopapillary ependymoma. A clinicopathologic study of 32 cases. Am J Clin Pathol. 1984;81:156–161
  18. Nakamura M, Ishii K, Watanabe K, et al. Surgical treatment of intramedullary spinal cord tumors: prognosis and complications. Spinal Cord. 2008;46:282–286
  19. Schild SE, Wong W, Nisi K. In regard to the radiotherapy of myxopapillary ependymomas. Int J Radiat Oncol Biol Phys. 2002;53:787
  20. Vanuytsel L, Brada M. The role of prophylactic spinal irradiation in localized intracranial ependymoma. Int J Radiat Oncol Biol Phys. 1991;21:825–830
  21. Paulino AC, Wen BC. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2000;47:585–589
  22. Shaw EG, Evans RG, Scheithauer BW, et al. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys. 1987;13:1457–1462
  23. Kovalic JJ, Flaris N, Grigsby PW, et al. Intracranial ependymoma long term outcome, patterns of failure. J Neurooncol. 1993;15:125–131
  24. Waldron JN, Laperriere NJ, Jaakkimainen L, et al. Spinal cord ependymomas: A retrospective analysis of 59 cases. Int J Radiat Oncol Biol Phys. 1993;27:223–229
  25. Monoranu C-M, Huang B, Zangen IL, et al. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet Cytogenet. 2008;182:18–26
  26. Pezzolo A, Capra V, Raso A, et al. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma. Cancer Lett. 2008;261:235–243
  27. Gavin Quigley D, Farooqi N, Pigott TJ, et al. Outcome predictors in the management of spinal cord ependymoma. Eur Spine J. 2007;16:399–404
  28. Hall WA, Merrill MJ, Walbridge S, et al. Epidermal growth factor receptors on ependymomas and other brain tumors. J Neurosurg. 1990;72:641–646
  29. Gilbertson RJ, Bentley L, Hernan R, et al. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res. 2002;8:3054–3064
  30. Mendrzyk F, Korshunov A, Benner A, et al. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res. 2006;12:2070–2079

 Conflicts of interest: none

PII: S0360-3016(08)03541-4

doi: 10.1016/j.ijrobp.2008.09.034

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 4 , Pages 1114-1120 , 15 July 2009

Article Tools

* Image Usage & Resolution